{
    "info": {
        "nct_id": "NCT04965987",
        "official_title": "A Phase I, Double-Blind, Pilot Study of Oxaloacetate in Myasthenia Gravis",
        "inclusion_criteria": "1. Patients 18 and older.\n2. Patients must have prior or current documentation of MGFA MG grades 2, 3, or 4A generalized MG, according to the MGFA classification system. These grades correspond to mild (2), moderate (3), and severe (4).\n3. A total MG-ADL score of greater than 3 at Screening and Baseline with no more than 50% of the total score being due to ocular symptoms.\n4. Patient's signs and symptoms should not be better explained by another disease process.\n5. Patients must be willing to complete the study and return for follow-up visits.\n6. Patients must be willing to give written informed consent before participating in this study. A copy of the signed consent must be kept in the patient's medical record.\n7. Patients can be on the following drugs as long as there has been no dose change for 60 days: azathioprine, cyclosporine, cyclophosphamide, mycophenolate mofetil, tacrolimus, methotrexate, IVIg or other immunosuppressive drugs.\n8. Patients can be on prednisone as long as there has been no dose change for 30 days.\n9. No planned changes in MG medications during the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. MGFA grade V within 6 months of screening.\n2. A history of chronic degenerative, severe psychiatric, or neurologic disorder other than MG that can produce weakness or fatigue.\n3. Other major chronic or debilitating illnesses within six months prior to study entry.\n4. Female patients who are premenopausal and are: (a) pregnant on the basis of a serum pregnancy test, (b) breast-feeding, or (c) not using an effective method of double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods) birth control (birth control pills, male condom, female condom, intrauterine device, Norplant, tubal ligation, or other sterilization procedures).\n5. Thymectomy in the previous three months.\n6. History of severe reactions to OAA\n7. Participation in a research study within the last 3 months",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "1. Patients 18 and older.",
                "criterions": [
                    {
                        "exact_snippets": "Patients 18 and older.",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Patients 18 and older.",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "9. No planned changes in MG medications during the study",
                "criterions": [
                    {
                        "exact_snippets": "No planned changes in MG medications during the study",
                        "criterion": "MG medications",
                        "requirement": {
                            "requirement_type": "planned change during the study",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "No planned changes in MG medications during the study",
                        "criterion": "MG medications",
                        "requirement": {
                            "requirement_type": "planned change during the study",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. A total MG-ADL score of greater than 3 at Screening and Baseline with no more than 50% of the total score being due to ocular symptoms.",
                "criterions": [
                    {
                        "exact_snippets": "A total MG-ADL score of greater than 3 at Screening and Baseline",
                        "criterion": "MG-ADL score",
                        "requirement": {
                            "requirement_type": "value at Screening",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "A total MG-ADL score of greater than 3 at Screening and Baseline",
                        "criterion": "MG-ADL score",
                        "requirement": {
                            "requirement_type": "value at Baseline",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "no more than 50% of the total score being due to ocular symptoms",
                        "criterion": "ocular symptoms contribution to MG-ADL score",
                        "requirement": {
                            "requirement_type": "percentage of total score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "A total MG-ADL score of greater than 3 at Screening and Baseline",
                                "criterion": "MG-ADL score",
                                "requirement": {
                                    "requirement_type": "value at Screening",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "A total MG-ADL score of greater than 3 at Screening and Baseline",
                                "criterion": "MG-ADL score",
                                "requirement": {
                                    "requirement_type": "value at Baseline",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "no more than 50% of the total score being due to ocular symptoms",
                        "criterion": "ocular symptoms contribution to MG-ADL score",
                        "requirement": {
                            "requirement_type": "percentage of total score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Patients must be willing to complete the study and return for follow-up visits.",
                "criterions": [
                    {
                        "exact_snippets": "Patients must be willing to complete the study",
                        "criterion": "willingness to complete the study",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "willing to ... return for follow-up visits",
                        "criterion": "willingness to return for follow-up visits",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Patients must be willing to complete the study",
                        "criterion": "willingness to complete the study",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "willing to ... return for follow-up visits",
                        "criterion": "willingness to return for follow-up visits",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. Patients must be willing to give written informed consent before participating in this study. A copy of the signed consent must be kept in the patient's medical record.",
                "criterions": [
                    {
                        "exact_snippets": "Patients must be willing to give written informed consent before participating in this study.",
                        "criterion": "willingness to give written informed consent",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients must be willing to give written informed consent before participating in this study.",
                        "criterion": "willingness to give written informed consent",
                        "requirement": {
                            "requirement_type": "consent type",
                            "expected_value": "written informed consent"
                        }
                    },
                    {
                        "exact_snippets": "A copy of the signed consent must be kept in the patient's medical record.",
                        "criterion": "signed consent copy in medical record",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Patients must be willing to give written informed consent before participating in this study.",
                        "criterion": "willingness to give written informed consent",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients must be willing to give written informed consent before participating in this study.",
                        "criterion": "willingness to give written informed consent",
                        "requirement": {
                            "requirement_type": "consent type",
                            "expected_value": "written informed consent"
                        }
                    },
                    {
                        "exact_snippets": "A copy of the signed consent must be kept in the patient's medical record.",
                        "criterion": "signed consent copy in medical record",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Patient's signs and symptoms should not be better explained by another disease process.",
                "criterions": [
                    {
                        "exact_snippets": "Patient's signs and symptoms should not be better explained by another disease process",
                        "criterion": "signs and symptoms",
                        "requirement": {
                            "requirement_type": "explanation by another disease process",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Patient's signs and symptoms should not be better explained by another disease process",
                        "criterion": "signs and symptoms",
                        "requirement": {
                            "requirement_type": "explanation by another disease process",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Patients can be on the following drugs as long as there has been no dose change for 60 days: azathioprine, cyclosporine, cyclophosphamide, mycophenolate mofetil, tacrolimus, methotrexate, IVIg or other immunosuppressive drugs.",
                "criterions": [
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: azathioprine",
                        "criterion": "azathioprine use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... cyclosporine",
                        "criterion": "cyclosporine use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... cyclophosphamide",
                        "criterion": "cyclophosphamide use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... mycophenolate mofetil",
                        "criterion": "mycophenolate mofetil use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... tacrolimus",
                        "criterion": "tacrolimus use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... methotrexate",
                        "criterion": "methotrexate use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... IVIg",
                        "criterion": "IVIg use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... other immunosuppressive drugs",
                        "criterion": "other immunosuppressive drug use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: azathioprine",
                        "criterion": "azathioprine use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... cyclosporine",
                        "criterion": "cyclosporine use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... cyclophosphamide",
                        "criterion": "cyclophosphamide use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... mycophenolate mofetil",
                        "criterion": "mycophenolate mofetil use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... tacrolimus",
                        "criterion": "tacrolimus use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... methotrexate",
                        "criterion": "methotrexate use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... IVIg",
                        "criterion": "IVIg use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on the following drugs ... as long as there has been no dose change for 60 days: ... other immunosuppressive drugs",
                        "criterion": "other immunosuppressive drug use",
                        "requirement": {
                            "requirement_type": "dose stability duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. Patients can be on prednisone as long as there has been no dose change for 30 days.",
                "criterions": [
                    {
                        "exact_snippets": "Patients can be on prednisone as long as there has been no dose change for 30 days.",
                        "criterion": "prednisone use",
                        "requirement": {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on prednisone as long as there has been no dose change for 30 days.",
                        "criterion": "prednisone use",
                        "requirement": {
                            "requirement_type": "dose change",
                            "expected_value": {
                                "operator": "=",
                                "value": 0,
                                "unit": "changes"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients can be on prednisone as long as there has been no dose change for 30 days.",
                        "criterion": "prednisone use",
                        "requirement": {
                            "requirement_type": "duration without dose change",
                            "expected_value": {
                                "operator": ">=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "Patients can be on prednisone as long as there has been no dose change for 30 days.",
                    "criterion": "prednisone use",
                    "requirement": {
                        "requirement_type": "use",
                        "expected_value": true
                    }
                },
                "then_criteria": {
                    "and_criteria": [
                        {
                            "exact_snippets": "Patients can be on prednisone as long as there has been no dose change for 30 days.",
                            "criterion": "prednisone use",
                            "requirement": {
                                "requirement_type": "dose change",
                                "expected_value": {
                                    "operator": "=",
                                    "value": 0,
                                    "unit": "changes"
                                }
                            }
                        },
                        {
                            "exact_snippets": "Patients can be on prednisone as long as there has been no dose change for 30 days.",
                            "criterion": "prednisone use",
                            "requirement": {
                                "requirement_type": "duration without dose change",
                                "expected_value": {
                                    "operator": ">=",
                                    "value": 30,
                                    "unit": "days"
                                }
                            }
                        }
                    ]
                },
                "else_criteria": null
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "6. History of severe reactions to OAA",
                "criterions": [
                    {
                        "exact_snippets": "History of severe reactions to OAA",
                        "criterion": "reactions to OAA",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    },
                    {
                        "exact_snippets": "History of severe reactions to OAA",
                        "criterion": "reactions to OAA",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "History of severe reactions to OAA",
                        "criterion": "reactions to OAA",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    },
                    {
                        "exact_snippets": "History of severe reactions to OAA",
                        "criterion": "reactions to OAA",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. A history of chronic degenerative, severe psychiatric, or neurologic disorder other than MG that can produce weakness or fatigue.",
                "criterions": [
                    {
                        "exact_snippets": "history of chronic degenerative ... disorder other than MG that can produce weakness or fatigue",
                        "criterion": "chronic degenerative disorder (other than MG)",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "history of chronic degenerative ... disorder other than MG that can produce weakness or fatigue",
                        "criterion": "chronic degenerative disorder (other than MG)",
                        "requirement": {
                            "requirement_type": "potential to produce weakness or fatigue",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "history of ... severe psychiatric ... disorder other than MG that can produce weakness or fatigue",
                        "criterion": "severe psychiatric disorder (other than MG)",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "history of ... severe psychiatric ... disorder other than MG that can produce weakness or fatigue",
                        "criterion": "severe psychiatric disorder (other than MG)",
                        "requirement": {
                            "requirement_type": "potential to produce weakness or fatigue",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "history of ... neurologic disorder other than MG that can produce weakness or fatigue",
                        "criterion": "neurologic disorder (other than MG)",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "history of ... neurologic disorder other than MG that can produce weakness or fatigue",
                        "criterion": "neurologic disorder (other than MG)",
                        "requirement": {
                            "requirement_type": "potential to produce weakness or fatigue",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "history of chronic degenerative ... disorder other than MG that can produce weakness or fatigue",
                                "criterion": "chronic degenerative disorder (other than MG)",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "history of chronic degenerative ... disorder other than MG that can produce weakness or fatigue",
                                "criterion": "chronic degenerative disorder (other than MG)",
                                "requirement": {
                                    "requirement_type": "potential to produce weakness or fatigue",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "history of ... severe psychiatric ... disorder other than MG that can produce weakness or fatigue",
                                "criterion": "severe psychiatric disorder (other than MG)",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "history of ... severe psychiatric ... disorder other than MG that can produce weakness or fatigue",
                                "criterion": "severe psychiatric disorder (other than MG)",
                                "requirement": {
                                    "requirement_type": "potential to produce weakness or fatigue",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "history of ... neurologic disorder other than MG that can produce weakness or fatigue",
                                "criterion": "neurologic disorder (other than MG)",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "history of ... neurologic disorder other than MG that can produce weakness or fatigue",
                                "criterion": "neurologic disorder (other than MG)",
                                "requirement": {
                                    "requirement_type": "potential to produce weakness or fatigue",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Female patients who are premenopausal and are: (a) pregnant on the basis of a serum pregnancy test, (b) breast-feeding, or (c) not using an effective method of double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods) birth control (birth control pills, male condom, female condom, intrauterine device, Norplant, tubal ligation, or other sterilization procedures).",
                "criterions": [
                    {
                        "exact_snippets": "Female patients",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "premenopausal",
                        "criterion": "menopausal status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "premenopausal"
                        }
                    },
                    {
                        "exact_snippets": "pregnant on the basis of a serum pregnancy test",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "test",
                            "expected_value": "serum pregnancy test"
                        }
                    },
                    {
                        "exact_snippets": "pregnant on the basis of a serum pregnancy test",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "pregnant"
                        }
                    },
                    {
                        "exact_snippets": "breast-feeding",
                        "criterion": "breast-feeding status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "not using an effective method of double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods) birth control (birth control pills, male condom, female condom, intrauterine device, Norplant, tubal ligation, or other sterilization procedures)",
                        "criterion": "birth control method",
                        "requirement": {
                            "requirement_type": "usage",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "not using an effective method of double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods) birth control (birth control pills, male condom, female condom, intrauterine device, Norplant, tubal ligation, or other sterilization procedures)",
                        "criterion": "birth control method",
                        "requirement": {
                            "requirement_type": "effectiveness",
                            "expected_value": "effective double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods)"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Female patients",
                                "criterion": "sex",
                                "requirement": {
                                    "requirement_type": "value",
                                    "expected_value": "female"
                                }
                            },
                            {
                                "exact_snippets": "premenopausal",
                                "criterion": "menopausal status",
                                "requirement": {
                                    "requirement_type": "value",
                                    "expected_value": "premenopausal"
                                }
                            }
                        ]
                    },
                    {
                        "or_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "pregnant on the basis of a serum pregnancy test",
                                        "criterion": "pregnancy status",
                                        "requirement": {
                                            "requirement_type": "test",
                                            "expected_value": "serum pregnancy test"
                                        }
                                    },
                                    {
                                        "exact_snippets": "pregnant on the basis of a serum pregnancy test",
                                        "criterion": "pregnancy status",
                                        "requirement": {
                                            "requirement_type": "value",
                                            "expected_value": "pregnant"
                                        }
                                    }
                                ]
                            },
                            {
                                "exact_snippets": "breast-feeding",
                                "criterion": "breast-feeding status",
                                "requirement": {
                                    "requirement_type": "value",
                                    "expected_value": true
                                }
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "not using an effective method of double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods) birth control (birth control pills, male condom, female condom, intrauterine device, Norplant, tubal ligation, or other sterilization procedures)",
                                        "criterion": "birth control method",
                                        "requirement": {
                                            "requirement_type": "usage",
                                            "expected_value": false
                                        }
                                    },
                                    {
                                        "exact_snippets": "not using an effective method of double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods) birth control (birth control pills, male condom, female condom, intrauterine device, Norplant, tubal ligation, or other sterilization procedures)",
                                        "criterion": "birth control method",
                                        "requirement": {
                                            "requirement_type": "effectiveness",
                                            "expected_value": "effective double barrier (1 hormonal plus 1 barrier method or 2 simultaneous barrier methods)"
                                        }
                                    }
                                ]
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. MGFA grade V within 6 months of screening.",
                "criterions": [
                    {
                        "exact_snippets": "MGFA grade V within 6 months of screening.",
                        "criterion": "MGFA grade V",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": "within 6 months of screening"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "MGFA grade V within 6 months of screening.",
                        "criterion": "MGFA grade V",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": "within 6 months of screening"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Participation in a research study within the last 3 months",
                "criterions": [
                    {
                        "exact_snippets": "Participation in a research study within the last 3 months",
                        "criterion": "participation in a research study",
                        "requirement": {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participation in a research study within the last 3 months",
                        "criterion": "participation in a research study",
                        "requirement": {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Thymectomy in the previous three months.",
                "criterions": [
                    {
                        "exact_snippets": "Thymectomy in the previous three months",
                        "criterion": "thymectomy",
                        "requirement": {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Thymectomy in the previous three months",
                        "criterion": "thymectomy",
                        "requirement": {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "2. Patients must have prior or current documentation of MGFA MG grades 2, 3, or 4A generalized MG, according to the MGFA classification system. These grades correspond to mild (2), moderate (3), and severe (4).",
                "criterions": [
                    {
                        "exact_snippets": "prior or current documentation of MGFA MG grades 2, 3, or 4A generalized MG, according to the MGFA classification system",
                        "criterion": "MGFA MG grade",
                        "requirement": {
                            "requirement_type": "grade",
                            "expected_value": [
                                "2",
                                "3",
                                "4A"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "prior or current documentation of MGFA MG grades 2, 3, or 4A generalized MG, according to the MGFA classification system",
                        "criterion": "MGFA MG grade",
                        "requirement": {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "3. Other major chronic or debilitating illnesses within six months prior to study entry.",
                "criterions": [
                    {
                        "exact_snippets": "Other major chronic or debilitating illnesses within six months prior to study entry.",
                        "criterion": "major chronic or debilitating illnesses",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Other major chronic or debilitating illnesses within six months prior to study entry.",
                        "criterion": "major chronic or debilitating illnesses",
                        "requirement": {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months prior to study entry"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Other major chronic or debilitating illnesses within six months prior to study entry.",
                        "criterion": "major chronic or debilitating illnesses",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Other major chronic or debilitating illnesses within six months prior to study entry.",
                        "criterion": "major chronic or debilitating illnesses",
                        "requirement": {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months prior to study entry"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "failed_miscellaneous": []
}